Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cannabis company, Vext Science (CSE:VEXT) has started production and sales of THC extracts for its Oklahoma joint venture, VAPEN OK
  • The joint venture’s product comes from its outdoor cultivation capacity and state-of-the-art processing and extraction facility
  • The VAPEN OK sales team is now selling VAPEN-branded products in Oklahoma’s licensed dispensaries
  • Oklahoma is one of the biggest markets for medical cannabis in the US, spending over C$350 million in 2019
  • Vext Science (VEXT) is down 6.67 per cent and is currently trading at 42 cents per share

Cannabis company, Vext Science (CSE:VEXT) has started production and sales of THC extracts for its Oklahoma joint venture, VAPEN OK.

The VAPEN-Oklahoma LLC venture will produce, market, and sell a full line of VAPEN-branded THC extract products. Its product comes from an outdoor cultivation capacity, which supplies quality biomass to a state-of-the-art processing and extraction facility.

The facility is now online, thanks to the venture’s on-site production team, and producing THC extracts for the VAPEN brand. The VAPEN OK sales team is already selling VAPEN-branded products in Oklahoma’s licensed dispensaries.

The State of Oklahoma is currently one of the biggest markets for medical cannabis in the United States.

The state has the highest number of dispensaries per 100,000 residents, in states with legalised medical marijuana. Over six per cent of the Oklahoman population holds a medical marijuana patient license.

In 2019, the citizens of Oklahoma spent over C$350 million on marijuana and marijuana-related products.

Vext Science’s CEO, Eric Offenburger, said that the company is successfully launching joint ventures in new states in 2020.

“With VAPEN OK fully operational, and the others coming on stream, we are demonstrating our ability to execute our growth strategy.

“We will continue to open new markets with in-state partners that have a vested interest in the success of our programs.

“Our growth model minimises operational and financial risks, while expanding our geographic presence with minimal capital investment,” he said.

Vext Science (VEXT) is down 6.67 per cent and is currently trading at 42 cents per share at 9:33am EDT.

More From The Market Herald
Isracann Biosciences Inc. - CEO, Phil Floucault

" Isracann Bioscience (CSE:IPOT) facilitated genetics arrive in Israel

Isracann Bioscience (IPOT) announces that its first shipment of cannabis strains has cleared Israeli customs and are being raised as mother stock.
Entourage Health - CEO and Executive Chairman, George Scorsis.

" Entourage (TSXV:ENTG) launches medical cannabis marketplace for the uninsured

Entourage (ENTG) has launched Syndicate, a direct-to-patient medical cannabis marketplace.

" Simply Better Brands (TSXV:SBBC) PureKana Brand, grows 362 per cent vs. one year ago

Simply Better Brands (SBBC) expands its brick-and-mortar retail footprint, which reflects wholesalers, drug stores, convenience stores, as well as CBD specialty retail.
CENTR Brands - CEO, Arjan Chima

" CENTR Brands Corp. (CSE:CNTR) announces net sales growth of over 240 per cent in FY2022

CENTR Brands Corp. (CNTR) announced its audited financial results for the year ending May 31, 2022.